Holen Sie sich die Stockscreener-App
9.67
1.15%
0.11
Handel nachbörslich:
9.67
Schlusskurs vom Vortag:
$9.56
Offen:
$9.56
24-Stunden-Volumen:
147.21K
Relative Volume:
0.54
Marktkapitalisierung:
$212.78M
Einnahmen:
$52.55M
Nettoeinkommen (Verlust:
$-23.69M
KGV:
-10.29
EPS:
-0.94
Netto-Cashflow:
$-15.29M
1W Leistung:
+8.53%
1M Leistung:
+38.34%
6M Leistung:
+126.46%
1J Leistung:
+217.57%
1-Tages-Spanne:
$9.43
$9.75
1-Wochen-Bereich:
$8.6932
$9.75
52-Wochen-Spanne:
$2.38
$9.75
Exagen Inc Stock (XGN) Company Profile
Firmenname
Exagen Inc
Sektor
Branche
Telefon
(760) 560-1501
Adresse
1261 LIBERTY WAY, VISTA, CA
Vergleichen Sie XGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
9.67 | 210.35M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-30 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-07-23 | Eingeleitet | Craig Hallum | Buy |
| 2022-08-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-04-15 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-06-02 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-10-14 | Eingeleitet | Cowen | Outperform |
| 2019-10-14 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Exagen Inc Aktie (XGN) Neueste Nachrichten
Exagen Inc. Stock Lags Behind Sector BenchmarksWeekly Risk Report & Consistent Profit Trading Strategies - 선데이타임즈
Comparing Exagen Inc. in custom built stock radarsCEO Change & Smart Swing Trading Alerts - Newser
Sector ETF Data Correlates with Strength in Exagen Inc.Quarterly Performance Summary & Weekly Setup with High ROI Potential - 선데이타임즈
What to expect from Exagen Inc. in the next 30 daysGDP Growth & Weekly Market Pulse Alerts - Newser
Key metrics from Exagen Inc.’s quarterly dataMarket Performance Recap & Growth Focused Stock Pick Reports - Newser
Applying Elliott Wave Theory to Exagen Inc.Weekly Stock Recap & Expert Verified Stock Movement Alerts - Newser
Applying chart zones and confluence areas to Exagen Inc.Real Market Tracker with Price Action Tools - Newser
What’s next for Exagen Inc. stock priceTrade Signal Summary & Safe Capital Allocation Plans - Newser
What candlestick patterns are forming on Exagen Inc. [Risk Management]Free Precise Trade Entry Recommendations - Newser
What recovery options are there for Exagen Inc.Market Timing Strategy with Technical Filters - Newser
What makes Exagen Inc. stock price move sharplyFree Entry Zone Strategy for Consistent Profit - Newser
Exagen Inc. stock outlook for YEARShort-Term Swing Opportunity Summary Sheet - Newser
Price action breakdown for Exagen Inc.Smart Forecast Signals from AI Models - Newser
Why Exagen Inc. stock attracts strong analyst attentionSecure Entry Point Finder with Analysis - Newser
Applying big data sentiment scoring on Exagen Inc.Swing Candidate List with Trade Cues - Newser
How to use a screener to detect Exagen Inc. breakoutsWeekly Entry Signal Based Forecast Tool - Newser
Exagen Inc. Recovery Gathers Momentum on Chart SignalsAI Based High Gain Watchlist Scanner Shared - beatles.ru
Is Exagen Inc. reversing from oversold territorySafe Entry Zone Based on Chart Analysis - Newser
What risks could impact Exagen Inc. stock performancePattern Breakout Entry Stock Forecast in Focus - metal.it
Building trade automation scripts for Exagen Inc.Free ROI Boosting Trade Opportunity Calendar - Newser
Exagen Inc. to Participate in Third Quarter Investor Conferences - The Manila Times
Exagen Doubles Down on Investor Outreach: Set for Major Healthcare Conference Circuit - Stock Titan
Exagen Inc.'s (NASDAQ:XGN) Share Price Boosted 26% But Its Business Prospects Need A Lift Too - simplywall.st
What drives Exagen Inc. stock priceFree Stock Market Beginners Guide - Jammu Links News
What are the latest earnings results for Exagen Inc.Discover breakthrough trading strategies - Jammu Links News
Is Exagen Inc. a good long term investmentMaximize your gains with expert trading tips - Jammu Links News
What are Exagen Inc. company’s key revenue driversBreakthrough financial growth - Jammu Links News
What are analysts’ price targets for Exagen Inc. in the next 12 monthsSuperior returns - Jammu Links News
What is the risk reward ratio of investing in Exagen Inc. stockBreakthrough profit margins - Jammu Links News
What catalysts could drive Exagen Inc. stock higher in 2025Build wealth steadily with smart stock selection - Jammu Links News
Is Exagen Inc. a growth stock or a value stockInvest smarter with advanced market data - Jammu Links News
Is Exagen Inc. stock overvalued or undervaluedMaximize gains with proven stock analysis - Jammu Links News
Is it the right time to buy Exagen Inc. stockRemarkably fast returns - Jammu Links News
What is the dividend policy of Exagen Inc. stockUnmatched profit potential - Jammu Links News
Exagen outlines $65M–$70M 2025 revenue target and positive adjusted EBITDA trajectory while advancing biomarker pipeline - MSN
Exagen Inc. (NASDAQ:XGN) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Exagen Inc. Reports Record Revenue Amidst Growth Challenges - The Globe and Mail
What markets is Exagen Inc. expanding into Is LILA stock a good long term investment optionExpert Picks Data Feed For Consistent Profits - Jammu Links News
Personalized Medicine Market Future Business Opportunities - openPR.com
Finanzdaten der Exagen Inc-Aktie (XGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.96%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):